TED TRIANA: Open Payments
NPI 1902892482 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,550 in 168 payments from 30 companies in 2025. Trend: 2023 $2,989 · 2024 $3,447 · 2025 $3,550
Food & beverage: $3,544Education: $6
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $433 |
| GlaxoSmithKline, LLC. | 19 | $364 |
| AstraZeneca Pharmaceuticals LP | 10 | $325 |
| Verona Pharma, Inc. | 11 | $225 |
| Novo Nordisk Inc | 6 | $205 |
| PFIZER INC. | 16 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $199 |
| Ardelyx, Inc. | 7 | $195 |
| Otsuka America Pharmaceutical, Inc. | 8 | $178 |
| Gilead Sciences, Inc. | 7 | $167 |
Products named: Kerendia, TRELEGY ELLIPTA, REXULTI, AIRSUPRA, Ohtuvayre, CAPLYTA, IBSRELA, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
